{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\", docket_id = \"FDA-2016-N-0124\" and posted_year = 2019 sorted by posted_date descending", "rows": [["FDA-2016-N-0124-0353", "FDA", "FDA-2016-N-0124", "FINAL Third Extension Deferral Letter from FDA CDER to American Cleaning Institute", "Other", "Letter(s)", "2019-10-17T04:00:00Z", 2019, 10, "2019-10-17T04:00:00Z", null, "2019-10-17T15:39:32Z", null, 0, 0, "09000064840b4539"], ["FDA-2016-N-0124-0352", "FDA", "FDA-2016-N-0124", "Lonza FINAL July 3_2019 Prelim Meeting Preliminary Comment for July 2019 MTG (002)", "Other", "Minutes", "2019-09-19T04:00:00Z", 2019, 9, "2019-09-19T04:00:00Z", null, "2019-09-19T18:24:21Z", null, 0, 0, "0900006483f9ee0c"], ["FDA-2016-N-0124-0351", "FDA", "FDA-2016-N-0124", "Letter from FDA CDER to American Cleaning Institute", "Other", "Letter(s)", "2019-08-09T04:00:00Z", 2019, 8, "2019-08-09T04:00:00Z", null, "2019-08-09T12:57:05Z", null, 0, 0, "0900006483e1e09f"], ["FDA-2016-N-0124-0350", "FDA", "FDA-2016-N-0124", "Letter from FDA CDER to American Cleaning Institute", "Other", "Letter(s)", "2019-07-15T04:00:00Z", 2019, 7, "2019-07-15T04:00:00Z", null, "2019-07-15T18:46:13Z", null, 0, 0, "0900006483d91e24"], ["FDA-2016-N-0124-0349", "FDA", "FDA-2016-N-0124", "LONZA Meeting Request for July 9 Cancelled", "Other", "Letter(s)", "2019-07-09T04:00:00Z", 2019, 7, "2019-07-09T04:00:00Z", null, "2019-07-09T15:55:34Z", null, 0, 0, "0900006483d6f60a"], ["FDA-2016-N-0124-0348", "FDA", "FDA-2016-N-0124", "Letter from FDA CDER to Lewis & Harrison", "Other", "Letter(s)", "2019-06-12T04:00:00Z", 2019, 6, "2019-06-12T04:00:00Z", null, "2019-09-19T16:52:24Z", null, 0, 0, "0900006483d09577"], ["FDA-2016-N-0124-0307", "FDA", "FDA-2016-N-0124", "Reference 20 - Kolawole, D. O., Resistance Mechanisms of Mucoid-Grown Staphylococcus aureus to the Antibacterial Action of Some Disinfectants re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:42Z", null, 0, 0, "0900006483b6a60c"], ["FDA-2016-N-0124-0318", "FDA", "FDA-2016-N-0124", "Reference 40 - Lanker Klossner, B., et al., Nondevelopment of Resistance by Bacteria During Hospital Use of Povidone-Iodine re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:52Z", null, 0, 0, "0900006483b6a95d"], ["FDA-2016-N-0124-0294", "FDA", "FDA-2016-N-0124", "Reference 2 \u2013 6 \u2013 Volume_V_5_of_9_Published_Cited_References_Part_2_of_2_ re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:32Z", null, 0, 0, "0900006483b6a5f0"], ["FDA-2016-N-0124-0325", "FDA", "FDA-2016-N-0124", "Reference 33 - Weber, D. J. and W. A. Rutala, Use of Germicides in the Home and the Healthcare re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:59Z", null, 0, 0, "0900006483b6a62c"], ["FDA-2016-N-0124-0333", "FDA", "FDA-2016-N-0124", "Reference 49 - Copitch, J. L., et al., Prevalence of Decreased Susceptibility to Triclosan in Salmonella re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:59:07Z", null, 0, 0, "0900006483b6a63f"], ["FDA-2016-N-0124-0344", "FDA", "FDA-2016-N-0124", "Reference 35 - Akinkunmi, E. O. and A. Lamikanra, Susceptibility of Community Associated Methicillin Resistant re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T19:00:48Z", null, 0, 0, "0900006483b6a62e"], ["FDA-2016-N-0124-0297", "FDA", "FDA-2016-N-0124", "Reference 2 \u2013 3 \u2013 Volume_IV_3_of_9_References_Continuation_ re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:34Z", null, 0, 0, "0900006483b6a4d3"], ["FDA-2016-N-0124-0343", "FDA", "FDA-2016-N-0124", "Reference 36 - Kawamura-Sato, K., et al., Reduction of Disinfectant Bactericidal Activities in Clinically Isolated Acinetobacter species in the re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T19:00:48Z", null, 0, 0, "0900006483b6a959"], ["FDA-2016-N-0124-0341", "FDA", "FDA-2016-N-0124", "Reference 41 - Oggioni, M. R., et al., Significant Differences Characterize the Correlation Coefficients Between Biocide and Antibiotic re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T19:00:46Z", null, 0, 0, "0900006483b6a960"], ["FDA-2016-N-0124-0312", "FDA", "FDA-2016-N-0124", "Reference 15 - Nagai, I. and H. Ogase, Absence of Role for Plasmids in Resistance to Multiple Disinfectants in Three re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:46Z", null, 0, 0, "0900006483b6a93b"], ["FDA-2016-N-0124-0320", "FDA", "FDA-2016-N-0124", "Reference 38 - Khor, S. Y. and M. Jegathesan, In-Use testing of Disinfectants in Malaysian Government Hospitals re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:54Z", null, 0, 0, "0900006483b6a95b"], ["FDA-2016-N-0124-0302", "FDA", "FDA-2016-N-0124", "Reference.List.Consumer.Rub.Final.Rule.2019 re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:38Z", null, 0, 0, "0900006483b6a46b"], ["FDA-2016-N-0124-0300", "FDA", "FDA-2016-N-0124", "Reference 2 - Comment submitted in Docket No. FDA-1975-N-0012-0081.  Volume_I_1_of_9_Soap_ and_Detergent_ re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:37Z", null, 0, 0, "0900006483b6a4cf"], ["FDA-2016-N-0124-0332", "FDA", "FDA-2016-N-0124", "Reference 50 - FDA Deferral Letter for Benzalkonium Chloride in Consumer Rub Antiseptics on October 31, 2017 re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:59:06Z", null, 0, 0, "0900006483b6a640"], ["FDA-2016-N-0124-0310", "FDA", "FDA-2016-N-0124", "Reference 17 - Sakagami, Y. and K. Kajimura, Bactericidal Activities of Disinfectants against Vancomycin re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:45Z", null, 0, 0, "0900006483b6a93d"], ["FDA-2016-N-0124-0345", "FDA", "FDA-2016-N-0124", "Reference 26 - Lacey, R. W., et al., Antiseptic Resistance in Methicillin-Resistant Staphylococcus aureus re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T19:00:49Z", null, 0, 0, "0900006483b6a625"], ["FDA-2016-N-0124-0347", "FDA", "FDA-2016-N-0124", "Reference 7 \u2013 1 FDA Deferral Letter for Isopropyl Alcohol in Consumer Rub Antiseptics on October 31, 2017 re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T19:00:51Z", null, 0, 0, "0900006483b6a929"], ["FDA-2016-N-0124-0309", "FDA", "FDA-2016-N-0124", "Reference 18 - Haley, C. E., et al., Bactericidal Activity of Antiseptics Against Methicillin-Resistant Staphylococcus re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:44Z", null, 0, 0, "0900006483b6a60a"], ["FDA-2016-N-0124-0346", "FDA", "FDA-2016-N-0124", "Reference 25 - Kunisada, T., et al., Investigation on the Efficacy of Povidone-Iodine Against Antiseptic re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T19:00:50Z", null, 0, 0, "0900006483b6a613"], ["FDA-2016-N-0124-0287", "FDA", "FDA-2016-N-0124", "Reference 4 -  Transcript of the October 20, 2005, Meeting of the Nonprescription Drugs Advisory Committee re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:28Z", null, 0, 0, "0900006483b6a925"], ["FDA-2016-N-0124-0321", "FDA", "FDA-2016-N-0124", "Reference 9 \u2013 Kramer, A., et. al., Quantity of Ethanol Absorption After Excessive Hand Disinfection Using Three Commercially re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:55Z", null, 0, 0, "0900006483b6a92c"], ["FDA-2016-N-0124-0313", "FDA", "FDA-2016-N-0124", "Reference 14 - Czerwinski, S. E., et al., Novel Water-Based Antiseptic Lotion Demonstrates Rapid, Broad- Spectrum Kill Compared re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:47Z", null, 0, 0, "0900006483b6a93a"], ["FDA-2016-N-0124-0292", "FDA", "FDA-2016-N-0124", "Reference 2 \u2013 8 \u2013 Volume_VII_7_of_9_References_Continuation_ re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:31Z", null, 0, 0, "0900006483b6a5f5"], ["FDA-2016-N-0124-0289", "FDA", "FDA-2016-N-0124", "Reference 2 \u2013 11 \u2013 Volume_IX_9_of_9_Publsihed_Cited_ References_Part_2_of_2_re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:29Z", null, 0, 0, "0900006483b6a5f8"], ["FDA-2016-N-0124-0286", "FDA", "FDA-2016-N-0124", "Reference 5 - Summary Minutes of the November 14, 2008, Feedback Meeting with Personal  re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:27Z", null, 0, 0, "0900006483b6a926"], ["FDA-2016-N-0124-0319", "FDA", "FDA-2016-N-0124", "Reference 39 - Rikimaru, T., et al., Bactericidal Activities of Commonly Used Antiseptics Against Multidrug-Resistant Mycobacterium re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:53Z", null, 0, 0, "0900006483b6a95c"], ["FDA-2016-N-0124-0327", "FDA", "FDA-2016-N-0124", "Reference 31 - Noguchi, N., et al., Susceptibilities to Antiseptic Agents and Distribution of Antiseptic- Resistance Genes qacAB and smr re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:59:01Z", null, 0, 0, "0900006483b6a62a"], ["FDA-2016-N-0124-0324", "FDA", "FDA-2016-N-0124", "Reference 34 - Rajamohan, G., et al., Biocide-Tolerant Multidrug-Resistant Acinetobacter baumannii Clinical Strains Are Associated with re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:58Z", null, 0, 0, "0900006483b6a62d"], ["FDA-2016-N-0124-0329", "FDA", "FDA-2016-N-0124", "Reference 29 - Babaei, M et al Extremely re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:59:03Z", null, 0, 0, "0900006483b6a628"], ["FDA-2016-N-0124-0311", "FDA", "FDA-2016-N-0124", "Reference 16 - Geraldo, I. M., et al., Rapid Antibacterial Activity of 2 Novel Hand Soaps re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:46Z", null, 0, 0, "0900006483b6a93c"], ["FDA-2016-N-0124-0315", "FDA", "FDA-2016-N-0124", "Reference 12 - Food and Drug Administration, Guidance for Industry. M3(R2) Nonclinical Safety Studies for the Conduct of re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:49Z", null, 0, 0, "0900006483b6a938"], ["FDA-2016-N-0124-0293", "FDA", "FDA-2016-N-0124", "Reference 2 \u2013 7 \u2013 Volume_VI_6_of_9_References_Continuation_ re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:32Z", null, 0, 0, "0900006483b6a5f4"], ["FDA-2016-N-0124-0290", "FDA", "FDA-2016-N-0124", "Reference 2 \u2013 10 \u2013 Volume_IX_9_of_9_References_Continuation_ re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:29Z", null, 0, 0, "0900006483b6a5f7"], ["FDA-2016-N-0124-0298", "FDA", "FDA-2016-N-0124", "Reference 2 \u2013 2 \u2013 Volume_III_3_of_9_Reference_List_re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:35Z", null, 0, 0, "0900006483b6a4d1"], ["FDA-2016-N-0124-0291", "FDA", "FDA-2016-N-0124", "Reference 2 \u2013 9 \u2013 Volume_VIII_8_of_9_References_Continuation_ re_ Comment_Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:30Z", null, 0, 0, "0900006483b6a5f6"], ["FDA-2016-N-0124-0288", "FDA", "FDA-2016-N-0124", "Reference 3 - Transcript of the March 23, 2005, Nonprescription Drugs Advisory Committee re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:28Z", null, 0, 0, "0900006483b6a5f9"], ["FDA-2016-N-0124-0305", "FDA", "FDA-2016-N-0124", "Reference 22 - Sivaji, Y., et al., Disinfectant Induced Changes in the Antibiotic Sensitivity and Phage Typing Pattern in Staphylococcus aureus re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:41Z", null, 0, 0, "0900006483b6a610"], ["FDA-2016-N-0124-0284", "FDA", "FDA-2016-N-0124", "Reference 7 - FDA Deferral Letter for Ethyl Alcohol in Consumer Rub Antiseptics on October 31, 2017 re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:25Z", null, 0, 0, "0900006483b6a928"], ["FDA-2016-N-0124-0295", "FDA", "FDA-2016-N-0124", "Reference 2 \u2013 5 \u2013 Volume_V_5_of_9_References_Continuation_ re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:33Z", null, 0, 0, "0900006483b6a4d5"], ["FDA-2016-N-0124-0338", "FDA", "FDA-2016-N-0124", "Reference 44 - Buffet-Bataillon, S., et al., Effect of Higher Minimum Inhibitory Concentrations of Quaternary Ammonium Compounds re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:59:11Z", null, 0, 0, "0900006483b6a63a"], ["FDA-2016-N-0124-0322", "FDA", "FDA-2016-N-0124", "Reference 8 \u2013 Brown, T. L., et al., Can Alcohol-Based Hand-Rub Solutions Cause You to Lose Your Driver\u2019s License Comparative  re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:56Z", null, 0, 0, "0900006483b6a92b"], ["FDA-2016-N-0124-0304", "FDA", "FDA-2016-N-0124", "Reference 23 - Young, R., et al., Comparative In Vitro Efficacy of Antimicrobial Shampoos A Pilot Study re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:40Z", null, 0, 0, "0900006483b6a611"], ["FDA-2016-N-0124-0323", "FDA", "FDA-2016-N-0124", "Reference 7 \u2013 2 FDA Deferral Letter for Benzalkonium Chloride in Consumer Rub Antiseptics on October 31, 2017 re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:57Z", null, 0, 0, "0900006483b6a92a"], ["FDA-2016-N-0124-0342", "FDA", "FDA-2016-N-0124", "Reference 37 - Kawamura-Sato, K., et al., Correlation Between Reduced Susceptibility to Disinfectants and Multidrug Resistance Among Clinical re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T19:00:47Z", null, 0, 0, "0900006483b6a95a"], ["FDA-2016-N-0124-0299", "FDA", "FDA-2016-N-0124", "Reference 2 \u2013 1 \u2013 Volume_II_2_of_9_Feedback_Meeting_and_Working_Texts_From_the_Feedback_ Meeting_March_29_1995_Attachment_1_through_6 re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:36Z", null, 0, 0, "0900006483b6a4d0"], ["FDA-2016-N-0124-0301", "FDA", "FDA-2016-N-0124", "Reference 1 - Transcript of the January 22, 1997, Joint Meeting of the Nonprescription Drugs and Anti re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:37Z", null, 0, 0, "0900006483b6a46c"], ["FDA-2016-N-0124-0308", "FDA", "FDA-2016-N-0124", "Reference 19 - Johnson, S. A., et al., Comparative Susceptibility of Resident and Transient Hand Bacteria to Para-chloro- re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:43Z", null, 0, 0, "0900006483b6a60b"], ["FDA-2016-N-0124-0334", "FDA", "FDA-2016-N-0124", "Reference 48 - Morrissey, I., et al., Evaluation of Epidemiological Cut-Off Values Indicates That Biocide Resistant Subpopulations Are Uncommon re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:59:08Z", null, 0, 0, "0900006483b6a63e"], ["FDA-2016-N-0124-0339", "FDA", "FDA-2016-N-0124", "Reference 43 - Stickler, D. J., et al., Antiseptic and Antibiotic Resistance in Gram-Negative Bacteria Causing Urinary re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T19:00:44Z", null, 0, 0, "0900006483b6a962"], ["FDA-2016-N-0124-0337", "FDA", "FDA-2016-N-0124", "Reference 45 - Shi, G. S., et al., Prevalence of Antiseptic-Resistance Genes in Staphylococci Isolated from re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:59:10Z", null, 0, 0, "0900006483b6a63b"], ["FDA-2016-N-0124-0340", "FDA", "FDA-2016-N-0124", "Reference 42 - Coelho, J. R., et al., The Use of Machine Learning Methodologies to Analyse Antibiotic and Biocide re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T19:00:45Z", null, 0, 0, "0900006483b6a961"], ["FDA-2016-N-0124-0335", "FDA", "FDA-2016-N-0124", "Reference 47 - Prince, H. N., et al., Drug Resistance Studies with Topical Antiseptics re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:59:09Z", null, 0, 0, "0900006483b6a63d"], ["FDA-2016-N-0124-0330", "FDA", "FDA-2016-N-0124", "Reference 28 - Furi, L., et al., Evaluation of Reduced Susceptibility to Quaternary Ammonium Compound re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:59:04Z", null, 0, 0, "0900006483b6a627"], ["FDA-2016-N-0124-0317", "FDA", "FDA-2016-N-0124", "Reference 10 \u2013 Miller, M. A., et. al., Does the Clinical Use of Ethanol-Based Hand Sanitizer Elevate Blood Alcohol Levels re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:51Z", null, 0, 0, "0900006483b6a92d"], ["FDA-2016-N-0124-0303", "FDA", "FDA-2016-N-0124", "Reference 24 - Block, C., et al., Evaluation of Chlorhexidine and Povidone Iodine Activity Against Methicillin-Resistant Staphylococcus re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:39Z", null, 0, 0, "0900006483b6a612"], ["FDA-2016-N-0124-0326", "FDA", "FDA-2016-N-0124", "Reference 32 - Shamsudin, M. N., et al., High Prevalence of qacAB Carriage Among Clinical Isolates of Meticillin-Resistant Staphylococcus re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:59:00Z", null, 0, 0, "0900006483b6a62b"], ["FDA-2016-N-0124-0328", "FDA", "FDA-2016-N-0124", "Reference 30 - Ghasemzadeh-Moghaddam, H., et al., Methicillin-Susceptible and-Resistant Staphylococcus aureus With High-Level Antiseptic re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:59:02Z", null, 0, 0, "0900006483b6a629"], ["FDA-2016-N-0124-0336", "FDA", "FDA-2016-N-0124", "Reference 46 - Lambert, R. J., Comparative Analysis of Antibiotic and Antimicrobial Biocide Susceptibility Data re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:59:10Z", null, 0, 0, "0900006483b6a63c"], ["FDA-2016-N-0124-0331", "FDA", "FDA-2016-N-0124", "Reference 27 - Liu, Q., et al., Sensitivities to Biocides and Distribution of Biocide Resistance Genes in Quaternary Ammonium Compound Tolerant re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:59:05Z", null, 0, 0, "0900006483b6a626"], ["FDA-2016-N-0124-0306", "FDA", "FDA-2016-N-0124", "Reference 21 - Sivaji, Y. and A. Mandal, Antibiotic Resistance and Serotypic Variations in Escherichia coli Induced by re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:42Z", null, 0, 0, "0900006483b6a60f"], ["FDA-2016-N-0124-0285", "FDA", "FDA-2016-N-0124", "Reference 6 - Transcript of the September 3, 2014, Meeting of the Nonprescription Drugs Advisory Committee 2014 re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:26Z", null, 0, 0, "0900006483b6a927"], ["FDA-2016-N-0124-0316", "FDA", "FDA-2016-N-0124", "Reference 11 \u2013 Food and Drug Administration, Guidance for Industry.  Maximal Usage Trials for Topical Active Ingredients Being Considered re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:50Z", null, 0, 0, "0900006483b6a937"], ["FDA-2016-N-0124-0296", "FDA", "FDA-2016-N-0124", "Reference 2 \u2013 4 \u2013 Volume_IV_4_of_9_Published_Cited_References_Part_2_of_2_ re_ Comment_ Soap_Detergent_ Association_ (SDA) re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:34Z", null, 0, 0, "0900006483b6a4d4"], ["FDA-2016-N-0124-0314", "FDA", "FDA-2016-N-0124", "Reference 13 - Bearden, D. T., et al., Comparative In Vitro Activities of Topical Wound Care Products Against re Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Supporting & Related Material", "Background Material", "2019-06-05T04:00:00Z", 2019, 6, null, null, "2019-06-05T18:58:48Z", null, 0, 0, "0900006483b6a939"], ["FDA-2016-N-0124-0283", "FDA", "FDA-2016-N-0124", "Briefing Document from Lewis and Harrison on behalf of Lonza Inc. and Henkel Consumer Goods, Inc.", "Other", "Brief", "2019-05-31T04:00:00Z", 2019, 5, "2019-05-31T04:00:00Z", null, "2019-05-31T20:36:58Z", null, 0, 0, "0900006483cddf54"], ["FDA-2016-N-0124-0281", "FDA", "FDA-2016-N-0124", "Safety and Effectiveness of Consumer Antiseptic Rubs; Topical Antimicrobial Drug Products for Over-the-Counter Human Use", "Rule", "Final Rule", "2019-04-12T04:00:00Z", 2019, 4, "2019-04-12T04:00:00Z", null, "2019-04-12T13:14:40Z", "2019-06791", 0, 0, "0900006483b89f68"], ["FDA-2016-N-0124-0279", "FDA", "FDA-2016-N-0124", "Letter from FDA CDER to Bayer Corporation", "Other", "Letter(s)", "2019-04-11T04:00:00Z", 2019, 4, "2019-04-11T04:00:00Z", null, "2019-04-11T16:48:48Z", null, 0, 0, "0900006483b85971"], ["FDA-2016-N-0124-0278", "FDA", "FDA-2016-N-0124", "Letter from FDA CDER to Ciba Specialty Chemicals Corporation", "Other", "Letter(s)", "2019-04-11T04:00:00Z", 2019, 4, "2019-04-11T04:00:00Z", null, "2019-04-11T16:46:32Z", null, 0, 0, "0900006483b856f5"], ["FDA-2016-N-0124-0280", "FDA", "FDA-2016-N-0124", "Letter from FDA CDER to Ciba Specialty Chemicals Corporation", "Other", "Letter(s)", "2019-04-11T04:00:00Z", 2019, 4, "2019-04-11T04:00:00Z", null, "2019-04-11T16:51:14Z", null, 0, 0, "0900006483b85974"], ["FDA-2016-N-0124-0277", "FDA", "FDA-2016-N-0124", "Request for a Type C Meeting from Lewis and Harrison on behalf of Lorenz  Inc., and Henkel Corporation", "Other", "Request", "2019-04-09T04:00:00Z", 2019, 4, "2019-04-09T04:00:00Z", null, "2019-04-09T19:01:15Z", null, 0, 0, "0900006483b7a9d3"], ["FDA-2016-N-0124-0276", "FDA", "FDA-2016-N-0124", "Request for a Deferral from Keller and Heckman LLP on behalf of CleanWell LLC", "Other", "Request", "2019-03-26T04:00:00Z", 2019, 3, "2019-03-26T04:00:00Z", null, "2019-03-26T21:16:11Z", null, 0, 0, "0900006483b319e2"], ["FDA-2016-N-0124-0275", "FDA", "FDA-2016-N-0124", "Report from American Cleaning Institute (ACI)", "Other", "Report", "2019-03-13T04:00:00Z", 2019, 3, "2019-03-13T04:00:00Z", null, "2019-03-13T20:22:54Z", null, 0, 0, "0900006483ad8541"]], "truncated": false, "filtered_table_rows_count": 78, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 and \"posted_year\" = :p2 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2016-N-0124", "p2": "2019"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0124&posted_year=2019", "results": [{"value": "FDA", "label": "FDA", "count": 78, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?docket_id=FDA-2016-N-0124&posted_year=2019", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0124&posted_year=2019", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 64, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0124&posted_year=2019&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 13, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0124&posted_year=2019&document_type=Other", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0124&posted_year=2019&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0124&posted_year=2019", "results": [{"value": 2019, "label": 2019, "count": 78, "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0124", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0124&posted_year=2019&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0124&posted_year=2019&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0124&posted_year=2019&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0124&posted_year=2019&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0124&posted_year=2019&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0124&posted_year=2019&_facet_date=comment_start_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-0124&posted_year=2019&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1603.0648639425635, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}